Increase of reactive oxygen species by desferrioxamine during experimental Chagas' disease

Redox Report

Volumn 15, Issue 4, 2010, Pages 185-190

  Francisco, Amanda Fortes ^a   De Abreu Vieira, Paula Melo ^a   Arantes, Jerusa Marilda ^b,c   Silva, Maisa ^a   Pedrosa, Maria Lúcia ^a   Elói Santos, Silvana Maria ^c   Martins Filho, Olindo Assis ^b   Teixeira Carvalho, Andréa ^b   Araújo, Márcio Sobreira Silva ^b   Tafuri, Washington Luiz ^a   Carneiro, Cláudia Martins ^a  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Chagas' disease; desferrioxamine; oxidative stress; Trypanosoma cruzi

Indexed keywords

DEFEROXAMINE; DEFEROXAMINE MESYLATE; GLUTATHIONE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; DRUG MECHANISM; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

ANIMALS; ANTIOXIDANTS; CHAGAS DISEASE; DEFEROXAMINE; DISEASE MODELS, ANIMAL; IRON CHELATING AGENTS; MALE; MICE; REACTIVE OXYGEN SPECIES; SIDEROPHORES; SUPEROXIDE DISMUTASE; TRYPANOSOMA CRUZI;

MURINAE; MUS; TRYPANOSOMA CRUZI;

EID: 77955071328     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/174329210X12650506623528     Document Type: Article

References (22)

1. Gupta S, Wen JJ, Garg NJ. Oxidative stress in Chagas' Disease. Interdiscip Perspect Infect Dis 2009; 2009: 190354.
2. Pedrosa ML, Silva ME, Silva ME, Silva MEC, Nicoli JR, Vieira EC. The effect of iron deficiency and iron overload on the evolution of Chagas' disease produced by three strains of Trypanosoma cruzi in CFWmice. Comp Biochem Physiol A 1990; 97: 235-243.
3. De Groote MA, Fang FC. NO inhibitions: Antimicrobial properties of nitric oxide. Clin Infect Dis 1995; 21 (Suppl. 2): S162-S165.
4. Becuwe P, Gratepanche S, Fourmaux MN et al. Characterization of iron-dependent endogenous superoxide dismutase of Plasmodium falciparum. Mol Biochem Parasitol 1996; 76: 125-134.
5. Zannineli G, Glickstein H, Breuer W, Brissot P, Hider RC, Cabantchik ZI. Chelation and mobilization of cellular iron by different classes of chelators. Mol Pharmacol 1997; 51: 842-852.
6. Kushner JP, Porter JP, Olivieri NF. Secondary iron overload. Hematol Am Soc Hematol Educ Program 2001; 1: 47-61.
7. Keberle H. The biochemistry of desferrioxamine and its relation to iron metabolism. Ann NY Acad Sci 1964; 119: 758-768.
8. Arantes JM, Pedrosa ML, Martins HR et al. Trypanosoma cruzi: treatment with the iron chelator desferrioxamine reduces parasitemia and mortality in experimentally infected mice. Exp Parasitol 2007; 117: 43-50.
9. Francisco AF, Vieira PMA, Arantes JM et al. Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice. Exp Parasitol 2008; 120: 314-319.
10. Lalonde RG, Holbein BE. Role of iron in Trypanosoma cruzi infection of mice. J Clin Invest 1984; 3: 470-476.
11. Loo VG, Lalonde RG. Role of iron in intracellular growth of Trypanosoma cruzi. Infect Immun 1984; 45: 726-730.
12. Silva LHP, Nussenzweig V. Sobre uma cepa altamente virulenta para o camundongo branco. Folia Clin Biol 1953; 20: 191-203.
13. Filardi LS, Brener Z. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas' Disease. Trans R Soc Trop Med Hyg 1987; 81: 755-759.
14. Levine RL, Garland D, Oliver CN et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464-478.
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
16. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-310.
17. Green LC, Wagner DA, Gloglowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and (15N)-nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
18. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 5: 323-350.
19. Philipp S, Cui L, Ludolph B, Kelm M, Schulz R, Cohen MV, Downey JM. Desferoxamine and ethyl-3,4-dihydroxybenzoate protect myocardium by activating noxidative stress and generating mitochondrial ROS. Am J Physiol 2006; 290: H450-H457.
20. Perez-Fuentes R, Torres-Rasgado E, Salgado-Rosas H, Zamora- Ginez I, Sanchez-Guillen MC. The anti-oxidant defence response in individuals with the indeterminate form of Chagas' disease (American trypanosomiasis). Ann Trop Med Parasitol 2008; 102: 189-197.
21. De Oliveira TB, Pedrosa RC, Wilhelm Filho D. Oxidative stress in chronic cardiopathy associated with Chagas' disease. Int J Cardiol 2007; 116: 357-363.
22. Fairlamb AH, Cerami A. Metabolism and functions of trypanothione in the kinetoplastida. Annu Rev Microbiol 1992; 46: 695-729.